Publication of the 2023-2024 Half-Year Financial Report Postponed Due to Completion of OCEANE Debt Refinancing By Investing.com Read more
Junshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature Medicine Read more
Mirati Therapeutics Announces Publication of Updated Clinical Data for Adagrasib By Investing.com Read more